Pinkerton Retirement Specialists, LLC Astrazeneca PLC Transaction History

Pinkerton Retirement Specialists, LLC

$689 Million
Q4 2024

A detailed history of Pinkerton Retirement Specialists, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pinkerton Retirement Specialists, LLC holds 63,430 shares of AZN stock, worth $4.74 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

63,430

Previous 64,735 2.02%

Holding current value

$4.74 Million

Previous $5.04 Million 17.62%

% of portfolio

0.6%

Previous 0.74%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $82,476 - $103,851	-1,305 Reduced 2.02%	63,430 $4.16 Million
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $499,811 - $571,194	6,519 Added 11.2%	64,735 $5.04 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $175,643 - $212,502	2,629 Added 4.73%	58,216 $4.54 Million
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $977,822 - $1.11 Million	16,022 Added 40.5%	55,587 $3.77 Million
Q4 2023 Jan 25, 2024	SELL	$61.89 - $69.28 $119,200 - $133,433	-1,926 Reduced 4.64%	39,565 $2.66 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $1,491 - $1,649	-23 Reduced 0.06%	41,491 $2.81 Million
Q2 2023 Aug 07, 2023	BUY	$69.91 - $75.81 $31,948 - $34,645	457 Added 1.11%	41,514 $2.97 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $48,562 - $55,060	769 Added 1.91%	41,057 $2.85 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $174,935 - $227,309	3,227 Added 8.71%	40,288 $2.73 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $133,716 - $342,361	-2,522 Reduced 6.37%	37,061 $2.03 Million
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $354,197 - $425,203	-5,977 Reduced 13.12%	39,583 $2.62 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $253,470 - $305,328	4,549 Added 11.09%	45,560 $3.02 Million
Q4 2021 Jan 24, 2022	BUY	$54.02 - $63.83 $91,617 - $108,255	1,696 Added 4.31%	41,011 $2.39 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $83,006 - $90,820	1,494 Added 3.95%	39,315 $2.36 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $54,230 - $67,401	1,120 Added 3.05%	37,821 $2.27 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $122,380 - $141,271	2,595 Added 7.61%	36,701 $1.83 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $69,335 - $82,910	-1,429 Reduced 4.02%	34,106 $1.71 Million
Q3 2020 Nov 06, 2020	SELL	$53.07 - $61.1 $111,128 - $127,943	-2,094 Reduced 5.56%	35,535 $1.95 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $445,697 - $571,960	10,341 Added 37.9%	37,629 $1.99 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $1.96 Million - $2.66 Million	-51,862 Reduced 65.52%	27,288 $1.22 Million
Q4 2019 Feb 11, 2020	BUY	$42.46 - $50.46 $54,518 - $64,790	1,284 Added 1.65%	79,150 $3.95 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $90,590 - $102,671	2,258 Added 2.99%	77,866 $3.47 Million
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $95,548 - $106,825	2,563 Added 3.51%	75,608 $3.12 Million
Q1 2019 May 10, 2019	BUY	$35.49 - $43.02 $225,361 - $273,177	6,350 Added 9.52%	73,045 $2.95 Million
Q4 2018 Feb 15, 2019	BUY	$36.86 - $41.49 $19,756 - $22,238	536 Added 0.81%	66,695 $2.53 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $5,770 - $6,593	-166 Reduced 0.25%	66,159 $2.62 Million
Q2 2018 Aug 13, 2018	SELL	$34.55 - $37.05 $249,589 - $267,649	-7,224 Reduced 9.82%	66,325 $2.33 Million
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $256,638 - $285,127	-7,784 Reduced 9.57%	73,549 $2.57 Million
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $56,285 - $61,004	1,754 Added 2.2%	81,333 $2.88 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $61,858 - $72,624	2,136 Added 2.76%	79,579 $2.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	77,443	77,443 $2.64 Million

Others Institutions Holding AZN

# of Institutions

1,353

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $232B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinkerton Retirement Specialists, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinkerton Retirement Specialists, LLC with notifications on news.

Account

Pinkerton Retirement Specialists, LLC Astrazeneca PLC Transaction History